Floatz logo

[68ga]ga-dota-cys-ath001

PSC

Antaros MedicalEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

21 Active assets in the PSC cohort.

Asset / SponsorPhaseRating
Vancomycin
Tampere University Hospital
Phase 4BB
URSODEOXYCHOLIC ACID
Assistance Publique - Hôpitaux de Paris
Phase 3BB
Aldafermin
NGM Biopharmaceuticals, Inc
Phase 2/3B
Elafibranor
Ipsen
Phase 3B
cm-101
ChemomAb Ltd.
Phase 2B

View all 50 →

Same molecule, other indications

[68ga]ga-dota-cys-ath001 is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
C
Indicative ·
39 / 100
View asset →
Healthy VolunteersDormant
C
Indicative ·
38 / 100
View asset →
Crohn diseaseDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →